.jpg) | |
| Discipline | Pharmacology,pharmacy |
|---|---|
| Language | English |
| Edited by | Lynne S. Taylor |
| Publication details | |
| History | 2004-present |
| Publisher | American Chemical Society (United States) |
| Frequency | Monthly |
| 5.364 (2021) | |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Mol. Pharm. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L | |
| CODEN | MPOHBP |
| ISSN | 1543-8384 (print) 1543-8392 (web) |
| LCCN | 2003212143 |
| OCLC no. | 51797065 |
| Links | |
Molecular Pharmaceutics is apeer-reviewedscientific journal covering research on the molecular mechanistic understanding ofdrug delivery and drug delivery systems, includingphysical andpharmaceutical chemistry,biochemistry andbiophysics,molecular andcellular biology, andpolymer andmaterials science.
First published in 2004 by theAmerican Chemical Society, it is considered one of the most prestigious journals in the field of pharmaceutics, physical pharmacy and drug delivery. Its publication frequency switched from bimonthly to monthly in 2012. According to theJournal Citation Reports, the journal has a 2021impact factor of 5.364.[1] The currenteditor-in-chief is Lynne S. Taylor, who is preceded foundingeditor-in-chief Gordon L. Amidon.
Molecular Pharmaceutics publishes reviews, research articles, brief articles, and communications.
The journal is abstracted and indexed in